ABCL Earnings

Quarterly EPS
$-0.17
Q3 2024
$-0.12
Q4 2024
$-0.15
Q1 2025
$-0.12
Q2 2025
$-0.19
Q3 2025
$-0.03
Q4 2025
$-0.14
Q1 2026
$-0.18
Q2 2026
Latest Revenue4.0M
Latest Net Income-55427000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.184.0M-55427000-76.3%-50.0%
Q1 2026-$0.148.3M-43165000+96.3%+6.7%
Q4 2025-$0.0344.9M-8945000+788.2%+75.0%
Q3 2025-$0.199.0M-57119000+37.6%-11.8%
Q2 2025-$0.1217.1M-34727000+133.3%+7.7%
Q1 2025-$0.154.2M-45621000-57.5%-7.1%
Q4 2024-$0.125.0M-34210000-45.0%+25.0%
Q3 2024-$0.176.5M-51107000-1.4%-70.0%
Q2 2024-$0.137.3M-36930000
Q1 2024-$0.1410.0M-40610000
Q4 2023-$0.169.2M-47150000
Q3 2023-$0.106.6M-28610000
AbCellera Biologics Inc. Common Shares (ABCL) — Earnings